162 related articles for article (PubMed ID: 12431068)
1. Nitric oxide releasing morpholine derivatives as hypolipidemic and antioxidant agents.
Chrysselis MC; Rekka EA; Siskou IC; Kourounakis PN
J Med Chem; 2002 Nov; 45(24):5406-9. PubMed ID: 12431068
[TBL] [Abstract][Full Text] [Related]
2. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
Chrysselis MC; Rekka EA; Kourounakis PN
J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
[TBL] [Abstract][Full Text] [Related]
3. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
Tooulia KK; Theodosis-Nobelos P; Rekka EA
Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
[TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry of 2,2,4-substituted morpholines.
Rekka EA; Kourounakis PN
Curr Med Chem; 2010; 17(29):3422-30. PubMed ID: 20712564
[TBL] [Abstract][Full Text] [Related]
5. A novel series of 2,6,7-substituted 2,3-dihydro-1,4-benzodioxin and 2,6,7-substituted 1,4-benzodioxin derivatives as lipid peroxidation inhibitors. Structure-activity relationships for high inhibition of human low-density lipoprotein peroxidation.
Thiéry V; Coudert G; Bizot-Espiard JG; Pfeiffer B; Renard P; Lindenbaum A; Guillaumet G
J Med Chem; 2001 Nov; 44(23):3904-14. PubMed ID: 11689076
[TBL] [Abstract][Full Text] [Related]
6. Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis.
Matralis AN; Bavavea EI; Incerpi S; Pedersen JZ; Kourounakis AP
Curr Med Chem; 2017; 24(12):1214-1227. PubMed ID: 27528055
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and effect on free radical processes on some substituted morpholine derivatives with potential biologic activity.
Tani E; Rekka E; Kourounakis PN
Arzneimittelforschung; 1994 Sep; 44(9):992-4. PubMed ID: 7986253
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory and Hypolipidemic Effect of Novel Conjugates with Trolox and Other Antioxidant Acids.
Theodosis-Nobelos P; Kourounakis PN; Rekka EA
Med Chem; 2017; 13(3):214-225. PubMed ID: 27823562
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
[TBL] [Abstract][Full Text] [Related]
10. NO-donor phenols: a new class of products endowed with antioxidant and vasodilator properties.
Boschi D; Tron GC; Lazzarato L; Chegaev K; Cena C; Di Stilo A; Giorgis M; Bertinaria M; Fruttero R; Gasco A
J Med Chem; 2006 May; 49(10):2886-97. PubMed ID: 16686532
[TBL] [Abstract][Full Text] [Related]
11. Design of more potent squalene synthase inhibitors with multiple activities.
Kourounakis AP; Matralis AN; Nikitakis A
Bioorg Med Chem; 2010 Nov; 18(21):7402-12. PubMed ID: 20888243
[TBL] [Abstract][Full Text] [Related]
12. NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterization.
Chegaev K; Lazzarato L; Rolando B; Marini E; Tosco P; Cena C; Fruttero R; Bertolini F; Reist M; Carrupt PA; Lucini V; Fraschini F; Gasco A
J Pineal Res; 2007 Apr; 42(4):371-85. PubMed ID: 17439554
[TBL] [Abstract][Full Text] [Related]
13. Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
Matralis AN; Kourounakis AP
J Med Chem; 2014 Mar; 57(6):2568-81. PubMed ID: 24568631
[TBL] [Abstract][Full Text] [Related]
14. Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity.
Katselou MG; Matralis AN; Kourounakis AP
Eur J Med Chem; 2017 Sep; 138():748-760. PubMed ID: 28728107
[TBL] [Abstract][Full Text] [Related]
15. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
Reddy KA; Lohray BB; Bhushan V; Reddy AS; Kishore PH; Rao VV; Saibaba V; Bajji AC; Rajesh BM; Reddy KV; Chakrabarti R; Rajagopalan R
Bioorg Med Chem Lett; 1998 May; 8(9):999-1002. PubMed ID: 9871696
[TBL] [Abstract][Full Text] [Related]
16. Syntheses and biological evaluation of 3-substituted amino-1-aryl-6-hydroxy-hex-2-ene-1-ones as antioxidant and hypolipidemic agents.
Batra S; Srivastava S; Singh K; Chander R; Khanna AK; Bhaduri AP
Bioorg Med Chem; 2000 Aug; 8(8):2195-209. PubMed ID: 11003164
[TBL] [Abstract][Full Text] [Related]
17. Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.
Ladopoulou EM; Matralis AN; Nikitakis A; Kourounakis AP
Bioorg Med Chem; 2015 Nov; 23(21):7015-23. PubMed ID: 26433631
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant effects of nitric oxide and nitric oxide donor compounds on low-density lipoprotein oxidation.
Goss SP; Kalyanaraman B; Hogg N
Methods Enzymol; 1999; 301():444-53. PubMed ID: 9919593
[TBL] [Abstract][Full Text] [Related]
19. Hybrid benzofuran-bisindole derivatives: new prototypes with promising anti-hyperlipidemic activities.
Sashidhara KV; Modukuri RK; Sonkar R; Rao KB; Bhatia G
Eur J Med Chem; 2013 Oct; 68():38-46. PubMed ID: 23954239
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
Sashidhara KV; Dodda RP; Sonkar R; Palnati GR; Bhatia G
Eur J Med Chem; 2014 Jun; 81():499-509. PubMed ID: 24871900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
